NDC 17772-0132-07
Qelbree (Viloxazine Hydrochloride)
Package · 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
150 mg/1 · Extended-Release Capsule
By Supernus Pharmaceuticals, Inc
Viloxazine Hydrochloride · Extended-Release Capsule · 150 mg
- NDC
- 17772-0132-07
- Route
- Oral
- Therapeutic class
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor , Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- NDA
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a Quote
Request this medication.
Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Neurological & Psychiatric
See all →
Guna-Mood
Solution / Drops
NDC 17089-0265-18
1 BOTTLE, DROPPER in 1 BOX (17089-265-18) / 30 mL in 1 BOTTLE, DROPPER
Available to Source
Neuro Links
Liquid
NDC 60564-0003-01
30 mL in 1 BOTTLE, DROPPER
Available to Source
Allergy Rescue
Liquid
NDC 43742-1249
Available to Source
New Stock Fungi Mix
.0000625 g/mL / .0000625 g/mL +14 · Solution
NDC 22840-9650
Available to Source